论文部分内容阅读
目的:分析根除幽门螺杆菌感染治疗慢性胃炎的临床疗效。方法:研究对象为我院在2010年至2013年12月期间收治的80例慢性胃炎病患,分为对照组和观察组各40例,其中对照组采用兰索拉唑单纯口服用药治疗,观察组在对照组基础上添加阿莫西林与克拉霉素干预治疗。结果:在治疗有效率上,观察组为95.00%,明显高于对照组77.50%;同时在幽门螺杆菌的根除率上,观察组为97.50%,对照组为82.50%,组间差异具有统计学意义,p<0.05。结论:通过阿莫西林、克拉霉素和兰索拉唑的联合治疗法,对于根除幽门螺杆菌感染治疗慢性胃炎具有高效、安全的临床效果,值得临床广泛推广。
Objective: To analyze the clinical efficacy of eradication of Helicobacter pylori infection in the treatment of chronic gastritis. Methods: The subjects were 80 chronic gastritis patients admitted in our hospital from 2010 to December 2013, divided into control group and observation group of 40 cases, the control group treated with lansoprazole alone oral medication, observed Group in the control group based on the addition of amoxicillin and clarithromycin intervention. Results: In the treatment efficiency, the observation group was 95.00%, significantly higher than the control group 77.50%; at the same time in the eradication rate of Helicobacter pylori, the observation group was 97.50%, the control group was 82.50%, the difference between groups was statistically Significance, p <0.05. Conclusion: The combination therapy of amoxicillin, clarithromycin and lansoprazole is effective and safe in eradicating Helicobacter pylori infection in the treatment of chronic gastritis. It is worth widely clinical application.